Saturday, 15 September 2018

Personalized Medicine for Heart

Track 18: 

Personalized Medicine - The Future


Personalized medicine is a medical model approach with all judgments and practices being tailored to individual patients in whatever ways possible. This treatment strategy allows the physician to provide a better therapy for patients in terms of efficiency, safety and treatment length to reduce the associated costs. And when used in patient treatment, personalized medicine is most often used in risk prevention (54 percent), genetic testing (53 percent) and lifestyle change (50 percent). Genetic assessments, combined with assessment of lifestyle risk factors including family history of cardiovascular disease determine if they are at greater risk for future health complications and thus provide steps they can take to lower their risk. All patients with the same disease condition receive the same first line treatment even though it may be only 30% to 60% effective. Therefore personalized treatment can be adapted to lesser the wastage of medicine and to reduce the cost of medication. Personalized medicine is likely to change the face of cardiovascular treatment in the near future.



Submit the abstract to the track: Personalized Medicine-The Future. 

Please contact the Program Coordinator for any queries at cardiology2018@gmail.com




No comments:

Post a Comment

Note: only a member of this blog may post a comment.

Evidence Supporting Niacin Use for CV Disease Prevention Evaluated

According to the results of a systematic review & meta-analysis, evidence supporting the clinical benefit of niacin monotherapy for se...

Announcement: Cardiology Summit 2018